Verition Fund Management’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-41,472
Closed -$232K 3580
2024
Q3
$232K Buy
41,472
+17,349
+72% +$121K ﹤0.01% 2794
2024
Q2
$203K Sell
24,123
-8,200
-25% -$87.4K ﹤0.01% 2588
2024
Q1
$467K Buy
+32,323
New +$534K ﹤0.01% 2035
2023
Q4
Sell
-12,978
Closed -$249K 2737
2023
Q3
$249K Buy
12,978
+2,340
+22% +$49.9K ﹤0.01% 1846
2023
Q2
$270K Buy
+10,638
New +$307K ﹤0.01% 1633
2022
Q1
Sell
-2,971
Closed -$241K 3091
2021
Q4
$241K Buy
+2,971
New +$298K ﹤0.01% 2131
2021
Q2
Sell
-1,647
Closed -$230K 2194
2021
Q1
$230K Sell
1,647
-1,448
-47% -$236K ﹤0.01% 1260
2020
Q4
$536K Buy
+3,095
New +$501K ﹤0.01% 655

Other funds holding NVRO

Verition Fund Management's NVRO Position: Q4 2024 in Review

Verition Fund Management sold out of NEVRO CORP. (NVRO) in Q4 2024, closing a stake of 41,472 shares — an estimated $232K sold.

Verition Fund Management first reported a position in NVRO in Q4 2020 and held it in 8 quarters. The position peaked at $536K in Q4 2020. 129 funds tracked by Wall St. Rank hold NVRO as of Q4 2024.

  • Verition Fund Management reported no remaining NEVRO CORP. position as of Q4 2024 after selling out during the quarter.
  • Verition Fund Management sold 41,472 NEVRO CORP. shares in Q4 2024, an estimated $232K.
  • Verition Fund Management first reported a position in NEVRO CORP. in Q4 2020 and held it in 8 quarters.
  • Verition Fund Management's NEVRO CORP. position peaked at $536K in Q4 2020.
  • 129 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2024.

Based on Verition Fund Management's 13F filing for Q4 2024, filed 14 Feb 2025.